From : 02 July , 2025 Wednesday 8 AM

To : 02 July , 2025 Wednesday 8 PM

AstraZeneca is set to launch Tagrisso in Ghana starting July 1. This breakthrough treatment for EGFR-mutated non-small cell lung cancer brings new hope to patients and oncology professionals nationwide. AstraZeneca, a global biopharmaceutical company, has been active in Ghana primarily through partnerships aimed at improving healthcare access and outcomes. In Ghana, AstraZeneca has supported initiatives related to non-communicable diseases (NCDs) such as hypertension, diabetes, and cancer. Notably, the company launched the Healthy Heart Africa (HHA) programme in Ghana, which focuses on raising awareness, providing screening, and improving access to treatment for hypertension and related cardiovascular conditions. AstraZeneca also collaborates with the Ghanaian Ministry of Health and local healthcare providers to strengthen healthcare systems and train health workers. Through such efforts, the company contributes to enhancing public health and supporting universal health coverage in Ghana.